Danaher stock gets a new CEO ahead of Q3 results

Published on 10/06/2026 at 17:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Danaher stock was trading at USD 217.59 on October 6, 2026. Q3 results are scheduled for October 21 as the CEO transition meets upgraded EPS guidance.

Börsen-Editorial des NYSE-Handelsplatzes mit DHR-Ticker und Life-Sciences-Kursdiagrammen — Danaher Corp. NYSE-Handelsparkett US2358511028 mit DHR-Ticker-Kursanzeige und sektorspezifischen Life-Sciences-Charts auf mehreren Bildschirmen, Illustration mit AI erstellt.

Danaher (ISIN US2358511028) was trading at USD 217.59 on the NYSE on October 6, 2026, down 1.64 percent from the previous close. The company has entered a leadership transition ahead of its third-quarter report, with Julie Sawyer Montgomery taking over as president and CEO on October 1, according to Danaher.

New CEO takes over before Q3

Montgomery also joined Danaher's board, while Rainer Blair is leaving the chief executive role. The change puts management execution at the center of the next earnings update, because the company is entering the second half with improving demand in parts of its portfolio.

Danaher's investor calendar lists the third-quarter 2026 earnings conference call for October 21, 2026, at 8:00 a.m. EDT, according to Danaher.

Q2 growth reached 4.5 percent

Danaher's second-quarter 2026 results provide the operating baseline for the leadership handoff. Sales reached USD 6.3 billion, while core revenue excluding respiratory testing increased 4.5 percent year over year, 150 basis points faster than in the first quarter, according to the company's earnings-call transcript on July 21, 2026, published by Yahoo Finance.

Adjusted diluted EPS was USD 1.94 in Q2 2026, and adjusted operating margin was 27.1 percent. Management raised full-year adjusted EPS guidance to USD 8.45-8.60 from USD 8.35-8.55, but shipment timing in bioprocessing pushed more than USD 100 million of activity into the following year, according to the same July 21 transcript published by Yahoo Finance.

RBC target reaches USD 250

RBC Capital raised its Danaher price target to USD 250 from USD 215 on October 5, 2026, while keeping an Outperform rating. The note attributed the increase to peer-group multiple expansion, making the target a valuation signal rather than a direct upgrade to operating forecasts, as reported by Markets Insider.

MarketBeat reported a Moderate Buy consensus from 24 analysts and an average target of USD 234.09 on October 5, 2026. That average is 7.58 percent above the October 6 intraday price, while RBC's USD 250 target is 14.91 percent above it, according to MarketBeat.

Danaher stock remains below its yearly high

Danaher stock was trading at USD 217.59 on October 6, 2026, with a session low of USD 215.17 and high of USD 227.61. Its 52-week range was USD 160.93-242.80, leaving the price 10.38 percent below the high and 35.22 percent above the low.